HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI) — PRIME  

Age-Associated Memory Impairment (AAMI) Clinical Trial

Official title: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Parallel-Group Study Comparing HT-0712 With Placebo in Subjects With Age-Associated Memory Impairment (AAMI)

Status Completed

Clinical Trial Summary

This is a Phase 2 randomized, multicenter, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of HT-0712 in improving memory and cognitive performance in subjects with Age-Associated Memory Impairment (AAMI)

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Age-Associated Memory Impairment (AAMI)
• Memory Disorders

• NCT number: NCT02013310
• Study type: Interventional
• Source: Dart NeuroScience, LLC
• Status: Completed
• Phase: Phase 2
• Start date: December 2013
• Completion date: January 2015